The Use of Antibiotic Sinonasal Rinse After Sinus Surgery
Condition:   Chronic RhinosinusitisInterventions:   Drug: Mupirocin;   Drug: PlaceboSponsor:   University of MiamiActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2014 Category: Research Source Type: clinical trials

The Use of Antibiotic Sinonasal Rinse After Sinus Surgery
Condition:   Chronic RhinosinusitisInterventions:   Drug: Mupirocin;   Drug: PlaceboSponsor:   University of MiamiActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2014 Category: Research Source Type: clinical trials

Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition:   Staphylococcal InfectionInterventions:   Drug: Mupirocin ointment;   Drug: Mupirocin creamSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2013 Category: Research Source Type: clinical trials

Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition:   Staphylococcal InfectionInterventions:   Drug: Mupirocin calcium;   Drug: Mupirocin calciumSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2013 Category: Research Source Type: clinical trials

Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition:   Staphylococcal InfectionInterventions:   Drug: Mupirocin calcium;   Drug: Mupirocin calciumSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2013 Category: Research Source Type: clinical trials

Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition:   Staphylococcal InfectionInterventions:   Drug: Mupirocin calcium;   Drug: Mupirocin calciumSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2013 Category: Research Source Type: clinical trials